Return to Special Authority drug list
Generic name |
abrocitinib |
---|---|
Strength & form |
50 mg, 100 mg, and 200 mg tablets |
Special Authority criteria |
Approval period |
---|---|
InitialFor the treatment of patients 12 years of age and older with moderate to severe atopic dermatitis (AD) if the following criteria are met:
AND
AND
|
6 months |
Renewals
AND
|
1 year |